Literature DB >> 452625

Itch in liver disease: facts and speculations.

C N Ghent, J R Bloomer.   

Abstract

Pruritus in hepatobiliary disease is commonly believed to be caused by retention of bile acids with their sequestration in the skin. HOwever, we have recently demonstrated that skin levels of bile acids in patients with cholestasis correlate poorly with pruritus. In this report, we present additional data concerning the relationship of pruritus to bile acid retention: (1) the urinary excretion of sulfated and nonsulfated bile acids was not significantly different in patients with cholestasis who itched compared to those who did not; (2) one patient with itch associated with a liver abscess had normal levels of bile acids in serum, skin, and urine; (3) patients with primary biliary cirrhosis who itched had lower serum bile acid levels than patients with mechanical biliary obstruction who did not itch.These studies support our premise that pruritus in hepatobiliary diseases is not directly related to bile acid retention. They suggest that the type of cholestatic disorder, and not simply the magnitude of the cholestasis, as estimated by the elevation of serum bile acids, is important. We propose that the agent responsible for pruritus is produced in response to cholestasis, possibly through activation of the alternate pathway of bile acid synthesis. Properties of the hypothetical pruritogen are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 452625      PMCID: PMC2595714     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  25 in total

1.  Relief of the pruritus of jaundice with a bile-acid sequestering resin.

Authors:  J B CAREY; G WILLIAMS
Journal:  JAMA       Date:  1961-05-06       Impact factor: 56.272

2.  Serum-bile-acid levels in liver disease.

Authors:  E C OSBORN; I D WOOTTON; L da SILVA; S SHERLOCK
Journal:  Lancet       Date:  1959-12-12       Impact factor: 79.321

3.  Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and topruritus.

Authors:  C N Ghent; J R Bloomer; G Klatskin
Journal:  Gastroenterology       Date:  1977-11       Impact factor: 22.682

4.  Serum-bile-acids in the stagnant-loop syndrome.

Authors:  B Lewis; S Tabaqchali; D Panveliwalla; I D Wootton
Journal:  Lancet       Date:  1969-02-01       Impact factor: 79.321

5.  Experimental alcoholic hepatic injury in man: ultrastructural changes.

Authors:  E Rubin; C S Lieber
Journal:  Fed Proc       Date:  1967-09

6.  Cholestyramine in uraemic pruritus.

Authors:  D S Silverberg; A Iaina; E Reisin; R Rotzak; H E Eliahou
Journal:  Br Med J       Date:  1977-03-19

7.  Efficacy and safety of long-term phenobarbital therapy of familial cholestasis.

Authors:  C N Ghent; J R Bloomer; Y E Hsia
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

8.  Primate biliary physiology. 8. The effect of phenobarbital upon bile salt synthesis and pool size, biliary lipid secretion, and bile composition.

Authors:  R N Redinger; D M Small
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

9.  PRURITUS AND JAUNDICE.

Authors:  N T MCPHEDRAN; R D HENDERSON
Journal:  Can Med Assoc J       Date:  1965-06-12       Impact factor: 8.262

10.  RELIEF OF THE PRURITUS OF JAUNDICE WITH METHANDROSTENOLONE AND SPECULATIONS ON THE NATURE OF PRURITUS IN LIVER DISEASE.

Authors:  J ALVA; F L IBER
Journal:  Am J Med Sci       Date:  1965-07       Impact factor: 2.378

View more
  6 in total

Review 1.  Jaundice associated pruritis: a review of pathophysiology and treatment.

Authors:  Ramez Bassari; Jonathan B Koea
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 2.  Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

3.  Pruritus in chronic hepatitis C: association with high serum bile acids, advanced pathology, and bile duct abnormalities.

Authors:  E Lebovics; F Seif; D Kim; A Elhosseiny; B M Dworkin; A Casellas; S Clark; W S Rosenthal
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

Review 4.  Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics.

Authors:  Mellar Davis
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

5.  [Pruritus and bile acids. Determination of sulfalithoglycocholate and glycocholate in suction blister fluid and in serum (author's transl)].

Authors:  W Bräuninger; K Bork; B Morsches; P Benes; G W Korting
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

6.  The impact of skin care products on skin chemistry and microbiome dynamics.

Authors:  Amina Bouslimani; Ricardo da Silva; Tomasz Kosciolek; Stefan Janssen; Chris Callewaert; Amnon Amir; Kathleen Dorrestein; Alexey V Melnik; Livia S Zaramela; Ji-Nu Kim; Gregory Humphrey; Tara Schwartz; Karenina Sanders; Caitriona Brennan; Tal Luzzatto-Knaan; Gail Ackermann; Daniel McDonald; Karsten Zengler; Rob Knight; Pieter C Dorrestein
Journal:  BMC Biol       Date:  2019-06-12       Impact factor: 7.431

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.